GLP-1 Dangers of Weight-Loss Medications Irregular Heartbeat Non-standard, unapproved weight-loss drugs can disrupt the digestive system, leading to abnormal heart function
These figures seemingly surpass the weight loss results associated with other weight loss products in the GLP-1 category, highlighting a potent clinical outcome of Zepbound
Comparative trials show that long-acting medications (exenatide once weekly, liraglutide, dulaglutide, and semaglutide) provide better glycemic control than short-acting medications (exenatide twice daily and lixisenatide) [90]
How does Retatrutide compare to gastric sleeve surgery
Lv XH, Lu Q, Deng K, et al
Result Literature search After searching three databases, including PubMed, Embase, and Cochrane Library, a total of 1127 reports were identified (368 from PubMed, 630 from Embase, and 129 from Cochrane Library)